ASP-based Reimbursement For Radiopharmaceuticals Gets PhRMA Support
Executive Summary
The Pharmaceutical Research and Manufacturers of America expressed support for using an average sales price-based approach to reimbursing radiopharmaceuticals under Medicare in response to CMS' statement of its willingness to consider switching from reimbursement based on individual hospitals' claims